Is Propolis Immune Support Randomized Trial safe?

Updated July 2026

Quick Answer

Propolis Immune Support Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: However, these modalities, particularly chemotherapy and radiotherapy, are associated with significant adverse effects, especially in tissues with a high cell turnover, such as the oral epithelium [].

Key Takeaways

  • 01However, these modalities, particularly chemotherapy and radiotherapy, are associated with significant adverse effects, especially in tissues with a high cell turnover, such as the oral epithelium []. [Assis Matheus de Morais (2026)]
  • 02When induced by chemotherapy, OM typically manifests during the first week of treatment, peaking around the eighth day; in radiotherapy-associated cases, severity usually increases from the second week onward []. [Assis Matheus de Morais (2026)]
  • 03Although reviews addressing the use of propolis in OM management are available, the present review differs by focusing exclusively on evidence derived from contemporary clinical trials and by providing a structured analysis of the different pharmaceutical formulations in relation to clinical efficacy. [Assis Matheus de Morais (2026)]
  • 041 2 3 4 5 Cancer is a malignant neoplasm resulting from genomic alterations and disruptions in the regulatory mechanisms of the cell cycle []. [Assis Matheus de Morais (2026)]
The current Migaku evidence database contains 2 reusable source documents for Propolis Immune Support Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - However, these modalities, particularly chemotherapy and radiotherapy, are associated with significant adverse effects, especially in tissues with a high cell turnover, such as the oral epithelium []. [Assis Matheus de Morais (2026); evidence level 3] - When induced by chemotherapy, OM typically manifests during the first week of treatment, peaking around the eighth day; in radiotherapy-associated cases, severity usually increases from the second week onward []. [Assis Matheus de Morais (2026); evidence level 3] - Although reviews addressing the use of propolis in OM management are available, the present review differs by focusing exclusively on evidence derived from contemporary clinical trials and by providing a structured analysis of the different pharmaceutical formulations in relation to clinical efficacy. [Assis Matheus de Morais (2026); evidence level 3] - 1 2 3 4 5 Cancer is a malignant neoplasm resulting from genomic alterations and disruptions in the regulatory mechanisms of the cell cycle []. [Assis Matheus de Morais (2026); evidence level 3] - Obesity develops as a result of the combined influence of genetic factors, social and economic conditions, and cultural lifestyle patterns. [İmre Kadriye Elif (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Clinical Evidence on the Use of Propolis for Oral Mucositis
  2. Propolis in Obesity and Related Metabolic Disorders: Mechanistic and Clinical Insights—A Scoping Review